Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenew Holdings Regulatory News (RNWH)

Share Price Information for Renew Holdings (RNWH)

Share Price is delayed by 15 minutes
Get Live Data
877.00    -1.00 (-0.11%)
Bid:
873.00
Ask:
877.00
Spread: 4.00 (0.458%)
Market Cap: £694.26m
RNWH Live PriceLast checked at - London Stock Exchange

Intraday Renew Holdings Share Chart

Director/PDMR Shareholding

7 Jan 2015 15:42

RNS Number : 5717B
Renew Holdings PLC
07 January 2015
 



 

 

Renew Holdings plc

("Renew" or the "Company")

 

Director/PDMR shareholding

Renew (AIM: RNWH), the Engineering Services Group supporting UK infrastructure, announces that a total of 293,000 options ("LTIP options") have been granted on 7 January 2015 to subscribe for ordinary shares of 10p each pursuant to the Company's Long Term Incentive Plan adopted on 25 January 2012. The grant includes the following allocation to directors of Renew:

B W May (Chief Executive)

109,000

J Samuel (Group Finance Director)

84,000

P Scott (Group Engineering Services Director)

60,000

 

At the same time, a total of 41,956 options to subscribe for ordinary shares of 10p each have been granted under an HMRC approved option scheme ("CSOP options") at an exercise price of 286p including the following allocation to directors of Renew:

 

B W May (Chief Executive)

10,489

J Samuel (Group Finance Director)

10,489

P Scott (Group Engineering Services Director)

10,489

 

The LTIP options are exercisable at a nominal cost from 8 January 2018 but are only exercisable to the extent that certain performance criteria are achieved by the Company over a three year performance period commencing 1 October 2014. The same performance criteria apply to the CSOP options which cannot be exercised until the same date as the LTIP options. Both sets of options must be exercised before 8 January 2022. To the extent that there is a gain arising on the CSOP options at the date of exercise, the option holder will forfeit LTIP options to the same value immediately. Following these grants, the total number of options outstanding over the Company's ordinary shares is 1,388,121.

 

A summary of the performance criteria is set out below.

 

Vesting of one half of the Options will be dependent on absolute growth in the Company's Total Shareholder Return ('TSR'), and the other half dependent on the Company's TSR performance as compared to the TSR achieved by other companies in a comparator group of nine companies selected by the Remuneration Committee. All TSR calculations will be based on the average of the opening and closing share price over a 30 day period prior to the commencement and end of the performance period.

 

The absolute TSR growth target requires the Company's TSR over the three year performance period to have grown by more than 25%. For TSR growth between 25% and 100%, the half of the Option which is subject to the absolute TSR growth target will vest on a straight-line basis from nil vesting at 25% growth, to 100% vesting at 100% growth. There will be no vesting if TSR growth is 25% or less.

 

The comparator group TSR performance target requires the Company's TSR to rank above the median TSR performance of the comparator group. If the Company's TSR performance is ranked between the median position and the top decile of the comparator group then the half of the Option which is subject to the comparator group TSR performance will vest on a straight line basis from nil vesting at or below the median, to 100% at the top decile. There will be no vesting at or below the median position.

 

 

 

Enquiries:

Renew Holdings plc

Tel: 0113 281 4200

Brian May, Chief Executive

John Samuel, Group Finance Director

Numis Securities Limited

Tel: 020 7260 1000

Stuart Skinner (Nominated Adviser)

James Serjeant (Corporate Broker)

Walbrook PR

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Bob Huxford

Mob: 07747 635 908 or bob.huxford@walbrookpr.com

 

About Renew Holdings plc

 

Engineering Services, which accounts for over 80% of Group revenue and 85% of operating profit, focuses on the key markets of Energy (including Nuclear), Environmental and Infrastructure, which are largely governed by regulation and benefit from non-discretionary spend with long-term visibility of committed funding.

Specialist Buildingfocuses on the High Quality Residential market in London and the Home Counties.

For more information please visit the Renew Holdings plc website: www.renewholdings.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFSELLIDIIE
Date   Source Headline
29th May 20262:12 pmRNSHolding(s) in Company
20th May 20263:12 pmRNSHolding(s) in Company
19th May 202611:20 amRNSHolding(s) in Company
19th May 20267:00 amRNSAcquisition of EDES
12th May 20267:00 amRNSHalf-year Report
11th May 20267:00 amRNSAcquisition of PWR-X Ltd
7th May 202612:44 pmRNSDirector/PDMR Shareholding
30th Apr 20267:00 amRNSAcquisition of Edwards Diving Services Limited
1st Apr 20264:55 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSH1 Trading Update and Notice of Results
29th Jan 202611:22 amRNSResult of AGM
29th Jan 20267:00 amRNSAGM Statement
26th Jan 20269:52 amRNSDirector/PDMR Shareholding
13th Jan 20264:01 pmRNSHolding(s) in Company
22nd Dec 20254:10 pmRNSDirector Dealing
22nd Dec 20254:10 pmRNSDirector Dealing
19th Dec 20257:00 amRNSPosting of ARA, AGM Notice & Listing Venue Update
19th Dec 20257:00 amRNSPosting of ARA, AGM Notice & Listing Venue Update
18th Dec 20257:00 amRNSDirector Dealing
25th Nov 20255:41 pmRNSFinal Results - Replacement
25th Nov 20257:00 amRNSFinal Results
28th Oct 20254:12 pmRNSHolding(s) in Company
27th Oct 20257:00 amRNSRevolving Credit Facility Refinancing
13th Oct 20257:00 amRNSAcquisition of Emerald Power Ltd
1st Oct 20257:00 amRNSYear End Trading Update & Notice of Results
8th Jul 20257:00 amRNSHolding(s) in Company
30th Jun 20258:34 amRNSChange of Nominated Adviser
13th May 20257:00 amRNSHalf-year Report
1st Apr 20257:00 amRNSH1 Trading Update and Notice of Results
4th Mar 202512:32 pmRNSHolding(s) in Company
20th Feb 20252:42 pmRNSHolding(s) in Company
12th Feb 202511:23 amRNSHolding(s) in Company
7th Feb 20253:10 pmRNSHolding(s) in Company
3rd Feb 202512:36 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSDirectorate Change
27th Jan 20256:03 pmRNSDirector / PDMR Shareholding
27th Jan 202512:00 pmRNSResult of AGM
24th Jan 20252:49 pmRNSDirector / PDMR Shareholding
24th Jan 20252:44 pmRNSDirector / PDMR Shareholding
24th Jan 20251:33 pmRNSDirector / PDMR Shareholding
24th Jan 20257:00 amRNSTrading Update
20th Dec 20247:00 amRNSAnnual Report & Accounts and Notice of AGM
18th Dec 20247:00 amRNSDirector Dealing
11th Dec 20245:04 pmRNSDirector Dealing
2nd Dec 202410:01 amRNSDirector/PDMR Shareholding
26th Nov 20247:00 amRNSFinal Results
16th Oct 20247:00 amRNSChange of Registered Office Address
15th Oct 20245:51 pmRNSHolding(s) in Company
7th Oct 20247:00 amRNSAcquisition of Full Circle
4th Oct 20247:00 amRNSDisposal of Walter Lilly & Co. Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.